Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a

Bausch + Lomb Corporation 10-K filed Feb 18, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 5:19 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business, against the 10-K filed Feb 19, 2025: 13 added · 5 removed · 44 modified; 15 with only figures updated

  1. Modified

    Bausch + Lomb understands that BHC continues to believe that completing the Separation, which may include the transfermonetization of all or a portion of BHC’s remaining direct or indirect equity ownership interest in Bausch + Lomb to its shareholders (, the sale of the Company (a “DistributionSale Transaction”), the monetizationtransfer of all or a portion of BHC’s ownership remaining direct or indirect equity interest in Bausch + Lomb, the sale of to its shareholders (the Company (a “Sale TransactionDistribution”), or a combination thereof, makes strategic sense and that BHC continues to evaluate all relevant factors and considerations related to completing the Separation, including those factors described in BHC’s public filings. The Distribution is subject to the achievement of targeted debt leverage ratios and the completion of the Separation is subject to the receipt of any applicable shareholder and other necessary approvals and other factors and is subject to various risk factors. See Item 1A. “Risk Factors” of this Form 10-K for additional information on the risks associated with the Separation. There can be no assurance that the Separation will be consummated, the form any such consummated Separation would take or that a Distribution or Sale Transaction will occur as part of that Separation or that even if consummated, we will realize the anticipated benefits from the Separation.